The University of Chicago Header Logo

Low-Strength Type I Interferon Signaling Promotes CAR T-Cell Treatment Efficacy.

Low-Strength Type I Interferon Signaling Promotes CAR T-Cell Treatment Efficacy. bioRxiv. 2025 May 20.

View in: PubMed